Xylem (NYSE:XYL) Rating Reiterated by TD Cowen

TD Cowen reissued their hold rating on shares of Xylem (NYSE:XYL) in a report published on Tuesday morning, MarketBeat.com reports. TD Cowen currently has a $138.00 target price on the industrial products company’s stock.

Several other research firms have also recently issued reports on XYL. Royal Bank of Canada raised their target price on Xylem from $160.00 to $163.00 and gave the stock an outperform rating in a research note on Wednesday, July 31st. Argus lifted their price objective on Xylem from $146.00 to $165.00 and gave the stock a buy rating in a research report on Wednesday, May 29th. Robert W. Baird boosted their target price on Xylem from $155.00 to $170.00 and gave the company an outperform rating in a research note on Wednesday, July 31st. Oppenheimer raised their price target on Xylem from $147.00 to $152.00 and gave the stock an outperform rating in a research note on Friday, May 31st. Finally, Stifel Nicolaus boosted their price objective on shares of Xylem from $170.00 to $172.00 and gave the company a buy rating in a research report on Wednesday, July 31st. Five investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Xylem has an average rating of Moderate Buy and an average price target of $147.54.

Xylem Price Performance

Shares of NYSE:XYL opened at $126.81 on Tuesday. The company’s fifty day moving average price is $134.13 and its 200-day moving average price is $133.70. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.85 and a quick ratio of 1.33. The firm has a market capitalization of $30.80 billion, a price-to-earnings ratio of 45.13, a PEG ratio of 2.27 and a beta of 1.04. Xylem has a one year low of $87.59 and a one year high of $146.08.

Xylem (NYSE:XYL) last announced its quarterly earnings data on Tuesday, July 30th. The industrial products company reported $1.09 earnings per share for the quarter, topping analysts’ consensus estimates of $1.05 by $0.04. Xylem had a net margin of 9.11% and a return on equity of 9.48%. The firm had revenue of $2.17 billion during the quarter, compared to analyst estimates of $2.14 billion. During the same period in the previous year, the business posted $0.98 EPS. The business’s quarterly revenue was up 26.0% on a year-over-year basis. On average, equities research analysts anticipate that Xylem will post 4.26 earnings per share for the current fiscal year.

Xylem Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 26th. Stockholders of record on Thursday, August 29th will be issued a dividend of $0.36 per share. The ex-dividend date is Thursday, August 29th. This represents a $1.44 annualized dividend and a dividend yield of 1.14%. Xylem’s dividend payout ratio (DPR) is currently 51.25%.

Insider Activity

In other Xylem news, CAO Geri-Michelle Mcshane sold 2,278 shares of the company’s stock in a transaction on Monday, June 10th. The shares were sold at an average price of $138.63, for a total value of $315,799.14. Following the sale, the chief accounting officer now directly owns 3,536 shares of the company’s stock, valued at $490,195.68. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 0.27% of the company’s stock.

Institutional Investors Weigh In On Xylem

A number of hedge funds have recently modified their holdings of XYL. EverSource Wealth Advisors LLC increased its holdings in shares of Xylem by 68.8% during the 1st quarter. EverSource Wealth Advisors LLC now owns 189 shares of the industrial products company’s stock worth $25,000 after buying an additional 77 shares during the last quarter. Mark Sheptoff Financial Planning LLC purchased a new stake in Xylem in the 2nd quarter valued at about $33,000. Blue Trust Inc. increased its position in shares of Xylem by 1,185.7% during the second quarter. Blue Trust Inc. now owns 270 shares of the industrial products company’s stock valued at $35,000 after acquiring an additional 249 shares during the last quarter. FinTrust Capital Advisors LLC raised its stake in shares of Xylem by 170.9% in the 1st quarter. FinTrust Capital Advisors LLC now owns 317 shares of the industrial products company’s stock valued at $41,000 after acquiring an additional 200 shares during the period. Finally, Hazlett Burt & Watson Inc. lifted its holdings in shares of Xylem by 184.9% in the 1st quarter. Hazlett Burt & Watson Inc. now owns 339 shares of the industrial products company’s stock worth $43,000 after acquiring an additional 220 shares during the last quarter. 87.96% of the stock is currently owned by institutional investors and hedge funds.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.